diagnostic-performance

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

1. 57/100

   Diagnostic performance of plasma p-tau217 in a memory clinic cohort using the Lumipulse automated platform

   ✓ Peer-reviewed alzhub usefulness score 57 out of 100. Alzheimer's research & therapy · 2025-03-27 · Biomarkers

   Plasma p-tau217 shows excellent results for detecting amyloid pathology at brain level in a clinical setting with an AUC of 0.95.

   • Biomarkers
   • Diagnosis
2. 52/100

   Assessing diagnostic performance of plasma biomarkers in Alzheimer's disease versus cognitively unimpaired individuals: P-tau217 emerges as the optimal marker in Chinese cohorts

   ✓ Peer-reviewed alzhub usefulness score 52 out of 100. Frontiers in aging neuroscience · 2025-03-26 · Biomarkers

   P-tau217 stands out as a highly effective biomarker for distinguishing AD from CUC, exhibiting extensive clinical application potential in the Chinese population.

   • Biomarkers
   • Diagnosis
3. 57/100

   Plasma p-tau212 antemortem diagnostic performance and prediction of autopsy verification of Alzheimer's disease neuropathology

   ✓ Peer-reviewed alzhub usefulness score 57 out of 100. Nature communications · 2024-03-23 · Biomarkers

   Blood phosphorylated tau (p-tau) biomarkers, including p-tau217, show high associations with Alzheimer's disease (AD) neuropathologic change and clinical stage.

   • Biomarkers
   • Brain Biology
   • Diagnosis
4. 71/100

   Diagnostic Performance of a Tablet Computer-Based Cognitive Screening Test for Identification of Amnestic Mild Cognitive Impairment

   ✓ Peer-reviewed alzhub usefulness score 71 out of 100. Journal of Korean medical science · 2023-05-01 · Cognitive tests and assessment

   Demographic and clinical characteristics between individuals with aMCI defined by the Inbrain CST and CERAD-K were not significantly different.

   • Diagnosis
   • Early Stage
5. 72/100

   The diagnostic performance of neurofilament light chain in CSF and blood for Alzheimer's disease, frontotemporal dementia, and amyotrophic lateral sclerosis: A systematic review and meta-analysis

   ✓ Peer-reviewed alzhub usefulness score 72 out of 100. Alzheimer's & dementia (Amsterdam, Netherlands) · 2019-11-04 · Biomarkers

   Comparable performance of CSF and blood NfL in many groups demonstrates the promise of NfL as a noninvasive biomarker of neurodegeneration; however, its utility in clinically meaningful scenarios requires greater scrutiny.

   • Biomarkers
   • Other Dementias
   • Diagnosis

All topic tags with their study counts